This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • BT for retinal detachment strabismus (2020)

BT for retinal detachment strabismus (2020)
Reviewed by Fiona Rowe

1 October 2021 | Fiona Rowe (Prof) | EYE - Paediatrics, EYE - Strabismus
Share This

The authors report updated experience on factors influencing botulinum toxin (BT) outcomes for strabismus following retinal detachment surgery. This was a retrospective review of 32 patients with follow-up of 20 months (1-132). Mean age at BT injection was 44 years (21-79) and 65% were male. Retinal surgery included pars plana vitrectomy in 62% and cryobuckling in 38%. Treatment response was graded as A – good if ≥50% reduction in baseline angle and / or reduction in diplopia or restored heterophoria; or B – poor if <50% reduction in baseline angle. Fifty percent were good or poor responders. The majority of poor responders had vitrectomy procedures (89%). Most had secondary exotropia. Eighteen percent with vertical or combined deviations had encirclement surgery. Repeat BT was needed with a mean of six to eight injections. Fifteen percent had complications including consecutive exotropia, secondary vertical deviation and intractable diplopia. The results show the potential for BT to restore ocular alignment and binocular vision. Poor response was associated with poor baseline vision and multiple retinal surgeries. There is a changing trend in surgery for retinal detachment. BT remains a useful alternative treatment for related strabismus.

Evolving trends in strabismus following retinal surgery is there still a role for botulinum toxin?
Moorthy S, Theodorou M, Hancox J, Adams GG.
STRABISMUS
2020;29(2):79-84.
Share This
Fiona Rowe (Prof)
CONTRIBUTOR
Fiona Rowe (Prof)

Institute of Population Health, University of Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency